Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Open Label Extension Study for Continued Safety and Efficacy Evaluation of Azeliragon in Patients With Mild Alzheimer's Disease

X
Trial Profile

Open Label Extension Study for Continued Safety and Efficacy Evaluation of Azeliragon in Patients With Mild Alzheimer's Disease

Status: Discontinued
Phase of Trial: Phase III

Latest Information Update: 03 Jun 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Azeliragon (Primary)
  • Indications Alzheimer's disease
  • Focus Adverse reactions; Registrational
  • Acronyms STEADFAST-Extension
  • Sponsors vTv Therapeutics LLC
  • Most Recent Events

    • 30 Apr 2018 Planned End Date changed from 1 Nov 2020 to 1 Jun 2018.
    • 30 Apr 2018 Planned primary completion date changed from 1 Nov 2020 to 9 May 2018.
    • 09 Apr 2018 Status changed from recruiting to discontinued, according to vTv Therapeutics media release.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top